PH94B

VistaGen finds open-label success with social anxiety nasal spray, but PALISADE pivotal trial remains iced
Fierce Biotech
Wed, 03/22/23 - 09:21 pm
VistaGen
nasal spray
social anxiety
open-label
PH94B
Vistagen, jittery after seeing rivals fail, pauses plan to restart phase 3 anxiety trial pending FDA talks
Fierce Biotech
Wed, 02/8/23 - 10:27 am
VistaGen
FDA
clinical trials
anxiety
PH94B
VistaGen can’t puff out phase 3 success for social anxiety nasal spray
Fierce Biotech
Fri, 07/22/22 - 11:24 am
VistaGen
social anxiety
clinical trials
PH94B
VistaGen says regulators couldn’t sniff out abuse potential of its nasal spray for social anxiety
Fierce Biotech
Sun, 05/8/22 - 12:14 pm
VistaGen
social anxiety
PH94B
clinical trials
FDA